The "Mar-A-Lago Accord" Is Now Underway

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

Sturm, Ruger & Co., Inc
NYSE:RGR
$44.21
Open 43.95 Prev Close 44.01
High 44.42 Low 43.70
Volume 189,239 Volume (Avg) 221
52 Week High 45.33 52 Week Low 31.49
Market Cap 714.5M PE Ratio 142.98

General

NameSturm, Ruger & Co., Inc
TickerRGR
ExchangeNYSE
SectorIndustrials
IndustryAerospace & Defense
CurrencyUSD
CountryUSA
Fiscal Year EndDecember

About Sturm, Ruger & Co., Inc

Sturm, Ruger & Company, Inc., together with its subsidiaries, designs, manufactures, and sells firearms under the Ruger name and trademark in the United States. It operates through two segments, Firearms and Castings. The company offers single-shot, autoloading, bolt-action, and modern sporting rifles; rimfire and centerfire autoloading pistols; single-action and double-action revolvers; and firearms accessories and replacement parts, as well as manufactures lever-action rifles under the Marlin name and trademark. It also provides steel investment castings and metal injection molding (MIM) parts. The company sells its firearm products to the commercial sporting market through independent wholesale distributors; and its investment castings and MIM parts directly or through manufacturers' representatives. It exports its firearm products through a network of selected commercial distributors and directly to foreign customers comprising primarily of law enforcement agencies and foreign governments. Sturm, Ruger & Company, Inc. was founded in 1949 and is headquartered in Southport, Connecticut.

Highlights

Analyst Target44.50
Market Cap714,500,000
PE Ratio142.98
EBITDA229,288,000

Valuation

Trailing PE133.36
Price/Sales (Trailing 12 Mt.)0.97
Price/Book (Most Recent Quarter)2.42

Technicals

Beta0.12
52 Week High45.33
52 Week Low31.49
50 Day Average21.21%
200 Day Average19.86%

Dividend

Sturm, Ruger & Co., Inc pays out a dividend of $0.71 per share, with a dividend yield of 1.61%.

RGR's last dividend payment was made to shareholders on August 29, 2025.

They pay out 38.99% of their earnings out as a dividend.

Recent Dividends

Aug 29, 2025$0.16
May 30, 2025$0.18
Mar 28, 2025$0.24
Nov 27, 2024$0.11
Aug 30, 2024$0.19
Jun 7, 2024$0.16
Mar 28, 2024$0.23
Nov 29, 2023$0.17
Most Popular

Nebius Vs. Palantir: The AI Infrastructure War At 100x Sales

Wall Street's AI mania has sparked a battle between Nebius (NBIS) and Palantir (PLTR) as investors question where the true value of AI lies.

Nvidia's Value Reaches $4.6 Trillion, Bitcoin Eyes $120,000: What's Moving Markets Thursday?

On the second day of the U.S. government shutdown, Wall Street remains largely subdued, with indexes showing only slight midday declines after touching fresh record highs at the open.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

FAA Faces Furlough Of 11,000 Employees, Airlines Warn Of Delays Amid Shutdown Threat

11,000 FAA employees face potential furloughs due to government funding lapse. ATC and TSA workers would work without pay.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Donald Trump's Approval Rating Crashes to Record Low — Here's What's Driving the Decline

According to the recent YouGov/Economist poll, President Trump's approval rating has taken a nosedive, reaching its lowest point in his second term.

OpenAI's Deal Machine Is in Overdrive—From CoreWeave To UiPath And Walmart

OpenAI has accelerated its partnership engine dramatically and is reshaping the tech, enterprise and retail landscapes at a dizzying pace.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

3 Gold Mining Stocks Shine As Prices Hit Records

Gold mining stocks Anglogold Ashanti, Coeur Mining, and New Gold join the top 10% for quality as gold prices hit fresh highs.

Want To Know the No.1 Crypto and the No.1 Stock? - Ad

The #1 crypto is just $3. Crypto analysts say a cash injection could drive it as high as $100 in the next year. The #1 stock is equally exciting. It's less than $10 but made a HUGE deal recently to work with Nvidia.

Why This Crypto Skeptic Had a Change of Heart - Ad

He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.

Ethereum Co-Founder Vitalik Buterin Responds to Security Concerns Over OpenAI's ChatGPT

Ethereum co-founder Vitalik Buterin has voiced his concerns over potential security risks associated with OpenAI's ChatGPT, which could lead to the leakage of personal user data.

BlackRock Turns Popular Mutual Funds Into Global Equity ETFs

BlackRock turns two top mutual funds into active ETFs, giving investors global equity exposure and strategies to manage volatility.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Johnson & Johnson's Tecvayli-Darzalex Combo Shows 100% Response In Newly Diagnosed Myeloma Patients

Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple myeloma patients.

Ex-Trump Lawyer Draws Parallels Between Kimmel Suspension And Nazi Regime

Ty Cobb has drawn a comparison between the suspension of comedian Jimmy Kimmel and the tactics employed by the Nazis.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Big Tech's energy-hungry data centers could be bumped off grids during power emergencies

HARRISBURG, Pa. (AP) — With the explosive growth of Big Tech's data centers threatening to overload U.S. electricity grids, policymakers are taking a hard look at a tough-love solution: bumping the energy-hungry data centers off grids during power emergencies.

Benzinga Bulls And Bears: Oracle, Micron, Land's End — And Ellison Briefly Bests Musk

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

How the Multiplier Effect is Working on This $3 Crypto - Ad

It's called the multiplier effect in crypto. In short, because of a lack of supply, small inflows of cash can create major moves in the overall value of the crypto. And it's particularly strong in one $3 crypto. Crypto analysts are suggesting it could rise to as high as $100 by next year.

Bitcoin Struggles Around $112,000, But Here's Why The Bull Run Is Not Over Yet

Bitcoin's (CRYPTO: BTC) is languishing around $112,000, but a prominent trader remains adamant about a strong end to the year.

Apple's iPhone 17 Series Takes Off, Meta's New Smart Glasses And Major Partnerships In AI Space: This Week In AI

This weekend's tech roundup featured Apple's strong iPhone 17 launch in China and India, Meta's new smart glasses, major AI partnerships like Intel-Nvidia and PayPal-Google, and Jim Cramer questioning Huawei's chip breakthrough.

Gold Is Being Reintroduced Into the Monetary System - Ad

While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.

Trump's $350 Billion Investment Demand Could Trigger 1997-Style Financial Crisis, Says South Korea's President

South Korean President Lee Jae Myung said that President Donald Trump's demands for a $350 billion investment in the U.S. could trigger a 1997-style Asian financial meltdown, without the necessary safeguards.

Kevin O'Leary Once Admitted He Wasn't The Best Dad — But The Shark Gave Himself A '10 Out Of 10' Score In One Key Area

Kevin O'Leary admitted he wasn't always present as a father but said financial stability made him a "10 out of 10" provider, sharing how tough-love lessons with his son and sacrifices echoed by Barack Obama and Mark Cuban highlight the trade-offs between family and success.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

Anthony Scaramucci Says A Tesla–xAI Merger 'Feels Inevitable' As Shareholders Push For Investment In Grok Parent

Anthony Scaramucci said a Tesla–xAI merger "feels inevitable," amplifying shareholder pressure and investor debate as Musk backs closer ties between the EV maker and his $100 billion AI startup.

Costco Wholesale, Concentrix And 3 Stocks To Watch Heading Into Friday

With U.S. stock futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows:

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

The Fed faces economic uncertainty and political pressure as it decides whether to cut rates

WASHINGTON (AP) — In a sign of how unusual this week's Federal Reserve meeting is, the decision it will make on — usually the main event — is just one of the key unknowns to be resolved when officials gather Tuesday and Wednesday.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Oracle's Big AI Bet Faces Credit Risk, Rating Agency Warns

Oracle (NYSE: ORCL) stock rises as AI deals boost investor confidence. However, Moody's warns of risks in $300B AI contracts with OpenAI.

Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?'

Sen. Elizabeth Warren (D-Mass.) on Thursday criticized the Centers for Disease Control and Prevention's vaccine advisory panel following its controversial vote to delay the combined measles, mumps, rubella, and varicella or MMRV vaccine for children under 4 years old.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Will electric tractors gain traction? At a pilot event for farmers, researchers see possibilities

EAST LANSING, Mich. (AP) — In the soft dirt of an indoor horseback riding ring last month, a group of farmers got ready to test drive a new piece of equipment: an electric tractor.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright markethundred.com
Privacy Policy | Terms of Service